NCAPG and Its Role in Endometrioid Cancer Progression
Author Information
Author(s): Ren Zhen, Li Xiaohan, Fu Chun
Primary Institution: The Second Xiangya Hospital of Central South University
Hypothesis
NCAPG promotes the malignant progression of endometrioid cancer through the LEF1/SEMA7A/PI3K-AKT pathway.
Conclusion
The study confirms that NCAPG enhances SEMA7A transcription, activating the PI3K/AKT pathway and promoting cancer cell proliferation, migration, and invasion.
Supporting Evidence
- NCAPG enhances the transcription of SEMA7A by modulating the chromatin accessibility of the transcription factor LEF1.
- SEMA7A binds to the PI3K regulatory subunit p85, activating the PI3K-AKT signaling pathway.
- High expression of LEF1 and SEMA7A correlates with advanced FIGO stage and myometrial invasion in endometrial cancer patients.
Takeaway
This study shows that a protein called NCAPG helps cancer cells grow and spread by affecting other proteins that control cell behavior.
Methodology
The study used ATAC-Seq, qRT-PCR, and Co-Immunoprecipitation to analyze the effects of NCAPG on endometrioid cancer cells.
Participant Demographics
Patients diagnosed with endometrioid carcinoma, with no prior hormonal therapy, radiotherapy, or chemotherapy.
Statistical Information
P-Value
1.00E-15
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website